Teladoc Health (TDOC)
(Delayed Data from NYSE)
$9.37 USD
+0.12 (1.30%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $9.36 -0.01 (-0.11%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth B Momentum B VGM
Price, Consensus and EPS Surprise
TDOC 9.37 +0.12(1.30%)
Will TDOC be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TDOC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TDOC
Teladoc (TDOC) Ascends While Market Falls: Some Facts to Note
Teladoc (TDOC) Ascends But Remains Behind Market: Some Facts to Note
TDOC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers (HIMS) Gains 37.7% in Three Months: What's Next?
Teladoc (TDOC) Stock Declines While Market Improves: Some Information for Investors
Teladoc (TDOC) Harnesses AI for Diabetes Care, Stock Rises 6.7%
Other News for TDOC
Teladoc's Vital Signs: Why 5x FCF Means Stable Health (Rating Upgrade)
3 Tech Stocks That Could Grow Your Wealth
Teladoc call volume above normal and directionally bullish
Teladoc Health to Announce Second Quarter 2024 Financial Results
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Argenx Se (ARGX) and AngioDynamics (ANGO)